# KERENDIA
> **NDA215341** · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2021-07-09
## Drug
- **FDA Application Number:** NDA215341
- **Application type:** New Drug Application
- **Brand name:** KERENDIA
- **Generic name:** FINERENONE
- **Active ingredients:** FINERENONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BAYER HLTHCARE
- **Manufacturer:** Bayer HealthCare Pharmaceuticals Inc.
- **First approval:** 2021-07-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215341)
---
*MORVS · CC0 1.0*